Year |
Citation |
Score |
2024 |
Galsky MD, Guan X, Rishipathak D, Rapaport AS, Shehata HM, Banchereau R, Yuen K, Varfolomeev E, Hu R, Han CJ, Li H, Liang Y, Vucic D, Wang L, Zhu J, et al. Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer. Cell Reports. Medicine. 101393. PMID 38280376 DOI: 10.1016/j.xcrm.2024.101393 |
0.338 |
|
2020 |
Zhang L, Li Z, Skrzypczynska KM, Fang Q, Zhang W, O'Brien SA, He Y, Wang L, Zhang Q, Kim A, Gao R, Orf J, Wang T, Sawant D, Kang J, ... ... Rapaport AS, et al. Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer. Cell. 181: 442-459.e29. PMID 32302573 DOI: 10.1016/J.Cell.2020.03.048 |
0.406 |
|
2020 |
Yu X, Zhang L, Chaudhry A, Rapaport AS, Ouyang W. Unravelling the heterogeneity and dynamic relationships of tumor-infiltrating T cells by single-cell RNA sequencing analysis. Journal of Leukocyte Biology. PMID 32272497 DOI: 10.1002/JLB.6MR0320-234R |
0.496 |
|
2015 |
Rapaport AS, Schriewer J, Gilfillan S, Hembrador E, Crump R, Plougastel BF, Wang Y, Le Friec G, Gao J, Cella M, Pircher H, Yokoyama WM, Buller RM, Colonna M. The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8(+) T Cells in Response to a Lethal Poxvirus Infection. Immunity. PMID 26680205 DOI: 10.1016/J.Immuni.2015.11.005 |
0.419 |
|
2014 |
KC W, Satpathy AT, Rapaport AS, Briseño CG, Wu X, Albring JC, Russler-Germain EV, Kretzer NM, Durai V, Persaud SP, Edelson BT, Loschko J, Cella M, Allen PM, Nussenzweig MC, et al. L-Myc expression by dendritic cells is required for optimal T-cell priming. Nature. 507: 243-7. PMID 24509714 DOI: 10.1038/Nature12967 |
0.455 |
|
2010 |
Albring JC, Sandau MM, Rapaport AS, Edelson BT, Satpathy A, Mashayekhi M, Lathrop SK, Hsieh CS, Stelljes M, Colonna M, Murphy TL, Murphy KM. Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression. The Journal of Experimental Medicine. 207: 2551-9. PMID 21078889 DOI: 10.1084/Jem.20102017 |
0.527 |
|
2008 |
Gilfillan S, Chan CJ, Cella M, Haynes NM, Rapaport AS, Boles KS, Andrews DM, Smyth MJ, Colonna M. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. The Journal of Experimental Medicine. 205: 2965-73. PMID 19029380 DOI: 10.1084/Jem.20081752 |
0.6 |
|
Show low-probability matches. |